Ascent Group’s Abiomed Inc ABMD Stock Holding History

Ascent Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,691	Closed	-$426K	–	484
2022 Q3	$426K	Sell	1,691 -21	-1%	-$5.67K	0.05%	316
2022 Q2	$502K	Buy	1,712 +72	+4%	+$19.4K	0.06%	295
2022 Q1	$543K	Buy	1,640 +155	+10%	+$47.7K	0.06%	286
2021 Q4	$452K	Buy	+1,485	New	+$502K	0.06%	312

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ascent Group's ABMD Position: Q4 2022 in Review

Ascent Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,691 shares — an estimated $426K sold.

Ascent Group first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $543K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Ascent Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Ascent Group sold 1,691 Abiomed Inc shares in Q4 2022, an estimated $426K.
Ascent Group first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
Ascent Group's Abiomed Inc position peaked at $543K in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ascent Group's 13F filing for Q4 2022, filed 17 Feb 2023.